147 related articles for article (PubMed ID: 15286661)
1. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation.
Ohkawa T; Naomoto Y; Takaoka M; Nobuhisa T; Noma K; Motoki T; Murata T; Uetsuka H; Kobayashi M; Shirakawa Y; Yamatsuji T; Matsubara N; Matsuoka J; Haisa M; Gunduz M; Tsujigiwa H; Nagatsuka H; Hosokawa M; Nakajima M; Tanaka N
Lab Invest; 2004 Oct; 84(10):1289-304. PubMed ID: 15286661
[TBL] [Abstract][Full Text] [Related]
2. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
3. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
[TBL] [Abstract][Full Text] [Related]
4. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.
Okawa T; Naomoto Y; Nobuhisa T; Takaoka M; Motoki T; Shirakawa Y; Yamatsuji T; Inoue H; Ouchida M; Gunduz M; Nakajima M; Tanaka N
Clin Cancer Res; 2005 Nov; 11(22):7995-8005. PubMed ID: 16299228
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
[TBL] [Abstract][Full Text] [Related]
7. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
9. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
10. Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.
Kobayashi M; Naomoto Y; Nobuhisa T; Okawa T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Mizushima T; Matsuura H; Nakajima M; Nakagawa H; Rustgi A; Tanaka N
Differentiation; 2006 Jun; 74(5):235-43. PubMed ID: 16759289
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer.
Han B; Liu J; Ma MJ; Zhao L
World J Gastroenterol; 2005 Apr; 11(14):2188-92. PubMed ID: 15810091
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
[TBL] [Abstract][Full Text] [Related]
13. Heparanase expression in clinical digestive malignancies.
Inoue H; Mimori K; Utsunomiya T; Sadanaga N; Barnard GF; Ueo H; Mori M
Oncol Rep; 2001; 8(3):539-42. PubMed ID: 11295076
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of heparanase and basic fibroblast growth factor expression in human non-small cell lung cancer].
Yu M; Li SY; Yu Z; Qiu XS; Hou P; Wang EH; Pecker I
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):36-41. PubMed ID: 15796880
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
[TBL] [Abstract][Full Text] [Related]
17. Heparanase expression correlates with malignant potential in human colon cancer.
Nobuhisa T; Naomoto Y; Ohkawa T; Takaoka M; Ono R; Murata T; Gunduz M; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Tsujigiwa H; Nagatsuka H; Nakajima M; Tanaka N
J Cancer Res Clin Oncol; 2005 Apr; 131(4):229-37. PubMed ID: 15625607
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
19. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence.
Doviner V; Maly B; Kaplan V; Gingis-Velitski S; Ilan N; Vlodavsky I; Sherman Y
Mod Pathol; 2006 Jun; 19(6):878-88. PubMed ID: 16607375
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
Zhang H; Chen W; Duan CJ; Zhang CF
World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
